Aptus Capital Advisors »

Intellia Therapeutics shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $91k 10k 8.99
2025-09-30 $1.2M 72k 17.27
2025-06-30 $706k 75k 9.38
2025-03-31 $633k 89k 7.11
2024-12-31 $1.6M 139k 11.66

More positions owned by Aptus Capital Advisors

Ishares Tr Iboxx Hi Yd Etf (HYG)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Select Sector Spdr Tr State Street Fin (XLF)
Etf Ser Solutions Aptus Defined (DRSK)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
salesforce (CRM)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Merck & Co (MRK)
Invesco Exch Trd Slf Idx Bulletshs 2032 (BSCW)
Invesco Exch Trd Slf Idx Buletshs 2031 Cp (BSCV)

View all positions for Aptus Capital Advisors

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Two Sigma Advisers
Dimensional Fund Advisors
Susquehanna International
FMR

View all funds holding Intellia Therapeutics